Holly Foot

405 total citations
22 papers, 267 citations indexed

About

Holly Foot is a scholar working on Family Practice, Geriatrics and Gerontology and Physiology. According to data from OpenAlex, Holly Foot has authored 22 papers receiving a total of 267 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Family Practice, 11 papers in Geriatrics and Gerontology and 7 papers in Physiology. Recurrent topics in Holly Foot's work include Medication Adherence and Compliance (16 papers), Pharmaceutical Practices and Patient Outcomes (10 papers) and Asthma and respiratory diseases (7 papers). Holly Foot is often cited by papers focused on Medication Adherence and Compliance (16 papers), Pharmaceutical Practices and Patient Outcomes (10 papers) and Asthma and respiratory diseases (7 papers). Holly Foot collaborates with scholars based in Australia, United Kingdom and New Zealand. Holly Foot's co-authors include Neil Cottrell, Adam La Caze, Ian Scott, Christopher Freeman, Nancy Sturman, Jennifer A. Whitty, Luke B. Connelly, Rob Horne, Amy Hai Yan Chan and Grant Russell and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer and Metastasis Reviews.

In The Last Decade

Holly Foot

17 papers receiving 262 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Holly Foot Australia 9 134 90 51 49 44 22 267
Wejdan Shahin Australia 7 117 0.9× 62 0.7× 22 0.4× 76 1.6× 25 0.6× 12 311
Susanne Jank Germany 8 188 1.4× 129 1.4× 61 1.2× 42 0.9× 72 1.6× 9 325
Nde-Eshimuni Salema United Kingdom 9 102 0.8× 170 1.9× 44 0.9× 94 1.9× 55 1.3× 23 318
Mhd Wasem Alsabbagh Canada 12 109 0.8× 127 1.4× 97 1.9× 77 1.6× 26 0.6× 39 453
Diego Ponieman United States 5 193 1.4× 96 1.1× 87 1.7× 148 3.0× 35 0.8× 6 520
Francisca Leiva-Fernández Spain 11 92 0.7× 80 0.9× 61 1.2× 99 2.0× 45 1.0× 35 389
Christopher Hand United Kingdom 5 103 0.8× 216 2.4× 93 1.8× 83 1.7× 62 1.4× 12 364
Aine Heaney Australia 7 69 0.5× 165 1.8× 144 2.8× 110 2.2× 24 0.5× 9 337
Sujata Sapkota Nepal 10 138 1.0× 89 1.0× 37 0.7× 61 1.2× 26 0.6× 25 338
Ester Amado Spain 11 56 0.4× 80 0.9× 54 1.1× 75 1.5× 18 0.4× 23 295

Countries citing papers authored by Holly Foot

Since Specialization
Citations

This map shows the geographic impact of Holly Foot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holly Foot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holly Foot more than expected).

Fields of papers citing papers by Holly Foot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Holly Foot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holly Foot. The network helps show where Holly Foot may publish in the future.

Co-authorship network of co-authors of Holly Foot

This figure shows the co-authorship network connecting the top 25 collaborators of Holly Foot. A scholar is included among the top collaborators of Holly Foot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Holly Foot. Holly Foot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Foot, Holly, et al.. (2025). Exploring the roles and impacts of pharmacists embedded in general practice: a scoping review. Journal of Pharmacy Practice and Research. 56(1). 47–61.
2.
Shrestha, Shakti, Holly Foot, Mahdi Sheikh, Marie‐Odile Parat, & Adam La Caze. (2025). Opioid use and the risk of cancer incidence and mortality: a systematic review. Cancer and Metastasis Reviews. 44(2). 54–54. 1 indexed citations
3.
Barras, Michael, et al.. (2025). A post-discharge pharmacist clinic to reduce hospital readmissions: a retrospective cohort study. International Journal of Clinical Pharmacy. 47(5). 1315–1323.
4.
Viljoen, Adie, Vivian Auyeung, Holly Foot, et al.. (2025). Physician and patient perspectives on the treatment of hypercholesterolaemia: a cross-sectional study to identify disconnects. Current Medical Research and Opinion. 41(7). 1291–1302.
5.
Guzman, Keshia R. De, Nazanin Falconer, Neil Cottrell, et al.. (2025). Pharmacist-Led Transition of Care Services in Patients with Cardiovascular Disease: A Systematic Scoping Review. Cardiology. 1–34.
7.
Foot, Holly, Kebede Beyene, Rob Horne, et al.. (2024). Evaluating the Feasibility of a Community Pharmacy-Delivered Behaviour Change Intervention to Reduce Reliever Reliance in Asthma. Patient Preference and Adherence. Volume 18. 361–371. 4 indexed citations
8.
Moon, Zoe, Alan Kaplan, Vincent Mak, et al.. (2024). The Reliever Reliance Test: evaluating a new tool to address SABA over-reliance. npj Primary Care Respiratory Medicine. 34(1). 36–36.
10.
López, Juan Carlos, et al.. (2023). Psychometric properties of the Spanish SABA Reliance Questionnaire (SRQ) among patients with asthma. SHILAP Revista de lepidopterología. 2(2). 100077–100077. 2 indexed citations
11.
Barras, Michael, et al.. (2023). The impact of hospital-based post-discharge pharmacist medication review on patient clinical outcomes: A systematic review. SHILAP Revista de lepidopterología. 11. 100305–100305. 9 indexed citations
12.
Foot, Holly, et al.. (2022). Enhanced primary care after hospitalization: General practitioner, pharmacist and patient feedback from the REMAIN HOME trial. Research in Social and Administrative Pharmacy. 19(3). 510–516. 1 indexed citations
13.
Pearce, Christina J., Amy Hai Yan Chan, Tracy Jackson, et al.. (2022). Features of successful interventions to improve adherence to inhaled corticosteroids in children with asthma: A narrative systematic review. Pediatric Pulmonology. 57(4). 822–847. 9 indexed citations
14.
Chan, Amy Hai Yan, Holly Foot, Christina J. Pearce, et al.. (2022). Effect of electronic adherence monitoring on adherence and outcomes in chronic conditions: A systematic review and meta-analysis. PLoS ONE. 17(3). e0265715–e0265715. 19 indexed citations
15.
Foot, Holly, Ian Scott, Nancy Sturman, et al.. (2021). Impact of pharmacist and physician collaborations in primary care on reducing readmission to hospital: A systematic review and meta-analysis. Research in Social and Administrative Pharmacy. 18(6). 2922–2943. 23 indexed citations
16.
Freeman, Christopher, Ian Scott, Karla Hemming, et al.. (2021). Reducing Medical Admissions and Presentations Into Hospital through Optimising Medicines (REMAIN HOME): a stepped wedge, cluster randomised controlled trial. The Medical Journal of Australia. 214(5). 212–217. 30 indexed citations
17.
Foot, Holly, Adam La Caze, Peter Baker, & Neil Cottrell. (2018). Better understanding the influence and complexity of beliefs on medication adherence in asthma. Patient Education and Counseling. 102(3). 564–570. 12 indexed citations
18.
Foot, Holly, Adam La Caze, & Neil Cottrell. (2017). Identifying the relationship between beliefs and medication adherence in asthma. Annals of Allergy Asthma & Immunology. 119(3). 284–285. 4 indexed citations
19.
Foot, Holly, Christopher Freeman, Karla Hemming, et al.. (2017). Reducing Medical Admissions into Hospital through Optimising Medicines (REMAIN HOME) Study: protocol for a stepped-wedge, cluster-randomised trial. BMJ Open. 7(4). e015301–e015301. 12 indexed citations
20.
Foot, Holly, et al.. (2015). The necessity–concerns framework predicts adherence to medication in multiple illness conditions: A meta-analysis. Patient Education and Counseling. 99(5). 706–717. 127 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026